Williamson Tea Kenya appoints Angus Omete as CEO
Williamson Tea Kenya names long-serving executive Angus Omete as CEO, marking a leadership transition as the company reports improved financial performance.
KENYA – Williamson Tea Kenya and its sister company Kapchorua Tea Kenya have appointed Angus Nyariki Omete as Managing Director and Chief Executive Officer, effective April 1, 2026.
Omete will succeed Alan Laurence Carmichael, who is set to retire on March 31, 2026 after serving in the role since 2008. The transition marks a leadership change at the tea companies as they continue to navigate evolving market conditions.
The incoming CEO currently serves as Group Chief Financial Officer and Executive Director and brings more than 26 years of experience in the tea industry.
He joined the company in November 1999 as a graduate trainee and has since held several senior positions, contributing to financial management, corporate strategy, governance and operations across the group.
Omete holds a Bachelor of Commerce (Accounting) degree from Kenyatta University and is a member of both the Institute of Certified Public Accountants of Kenya and the Institute of Certified Secretaries.
In a statement, the company expressed confidence in the new leadership. “The Board congratulates Angus on his appointment and is confident that he will steer the Group through its next phase of sustainable, value-driven growth,” it said.
Earlier this year, in February, Omete was appointed Executive Director, taking over from Samuel Ndungu Thumbi, who retired after 44 years of service.
The leadership transition comes as the companies report mixed financial results. For the six months ended September 30, 2025, Williamson Tea Kenya narrowed its net loss to Kes 10 million (US$77,000), compared with a loss of Kes 122.4 million (US$942,000) in the same period the previous year.
Kapchorua Tea Kenya, however, reported strong profitability, posting a net profit of Kes 95 million (US$731,000), representing a 422% increase from Kes 18.2 million (US$140,000) a year earlier. This growth was recorded despite a 24% decline in revenue to Kes 1.1 billion (US$8.46 million).
The increase in profit was largely driven by a rise in the fair value of biological assets, which grew to Kes 39.4 million (US$303,000) from Kes 7.9 million (US$61,000) in the previous year.
Sign up HERE to receive our email newsletters with the latest news and insights from Africa and around the world, and follow us on our WhatsApp channel for updates.
